"Zhongyuan company assisted in scientific research -- antibody and cell model technology seminar" was successfully held
On June 15, 2018, “Beijing Zhongyuan Ltd.'s Workshop on Helping Scientific Research – Antibody and Cell Model Technology” was successfully held at Crowne Plaza Beijing. The conference successfully invited Dr. Xue Xiaobo, a senior technical expert of abcam, to share the wonderful "focus on antibody quality and help scientific research"; invited ATCC chief scientist, head of cell biological preservation center - Dr. Tian Fang, to "use basic research and The advanced cell model of drug development has been wonderfully shared. The conference received attention from scientific research units in Beijing and its surrounding areas, pharmaceutical companies and universities, and nearly 100 participants. In addition, the face-to-face technical exchanges that took place after the meeting sparked heated discussions among the participants.
Sign in to the scene
Before the meeting, the staff arrived at the venue early and arranged the venue. Participants were even more enthusiastic and rushed to the scene in advance. The picture shows the participants signing the scene.
Dr. Xue’s speech
Dr. Xue explained a series of questions about the quality of antibodies and gave a detailed explanation on their production, principle of action, and development trends. Ultimately, an in-depth discussion of how to screen for the best antibodies can speed up your diagnosis and treatment research.
After Dr. Xue’s lecture ended, the lucky draw was held for everyone; the picture shows the winning person taking a group photo with Dr. Xue.
Dr. Tian’s speech
Dr. Tian detailed a series of new cell models from the ATCC that will facilitate basic research and drug development. These include drug-resistant human cell lines created using CRISPR/cas9 gene editing technology, as well as hTERT immortalized cell lines, induced pluripotent stem cells (iPSCs), 3D culture techniques, and primary cells. It also describes the use of novel cell models for cancer, toxicology and neurobiology in basic and preclinical studies, as well as the use of human cells and microbial derivatives as controls for molecular diagnostic analysis.
During the lectures by Dr. Tian, the participants listened carefully, actively interacted, and raised many issues of great concern. Dr. Tian answered them one by one and relieved doubts for everyone.
After the end of Dr. Tian’s lecture, the second round of the lucky draw was held; the picture shows the winning person taking a group photo with Dr. Tian.
After the lecture, senior experts from various research institutes conducted in-depth technical discussions and exchanges with Dr. Tian.